Skip to main content
. 2018 Oct 19;8:15514. doi: 10.1038/s41598-018-33833-w

Table 3.

The mother-to-child transmission rates and the serum HBV DNA recovery of the mothers at 28 weeks postpartum.

TDF treatment Control value p
Cases (n) % Cases (n) %
Mother-to-child Transmission 8.338 0.004
  Occurred 0 0% 7 13.5%
  Did not occur 59 100% 45 86.5%
Serum HBV DNA 28 weeks postpartum 21.916 0.000003
  ≤2000 IU/mL 20 33.9% 0 0%
  Recovery to the original level 39 66.1% 52 100%